Chromocell Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -466 | -2,579 | ||
EBITDA | -1,655 | -1,764 | -1,933 | -3,878 |
EBIT | -2,048 | -1,767 | -3,867 | -7,757 |
Net Income | -1,694 | -1,771 | -2,562 | -4,039 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -177 | -2,952 | -1,991 | -356 |
Cash | 1,254 | 2,405 | 3,770 | 96 |
Basic Shares | 5,792 | 5,773 | 5,766 | 5,877 |
Annual Financials
| Values in thousands | 2023-12-31 | 2023-09-30 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -2,579 | -391 | |
EBITDA | -6,862 | -1,627 | |
EBIT | -13,724 | -2,318 | |
Net Income | -7,380 | -7,380 | -2,458 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -981 | -981 | -1,567 |
Cash | 96 | 96 | 55 |
Basic Shares | 5,767 | 5,767 | 5,767 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.29 |
2024-06-30 | -$0.31 |
2024-03-31 | -$0.44 |
